COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters
- 74 Downloads
Epidemiological studies suggest that regular intake of nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with reduced incidence of gastrointestinal cancer. Several lines of evidence indicate that the antineoplastic effect of NSAIDs is attributable to COX-2 inhibition. The aim of our study was to assess COX-2 expression in a series of primary untreated ampullary carcinomas and its possible correlation with clinicopathological parameters. In the present study, 45 surgical specimens of invasive ampullary carcinomas were histologically classified into pancreaticobiliary, intestinal, and unusual types. COX-2 expression by immunohistochemical method was analyzed. High COX-2 expression was detected in 35 (77.8%) ampullary carcinomas. Among these, 20/21 (95.2%) were classified as intestinal, 9/18 (50%) pancreaticobiliary, and 6/6 (100%) unusual type. A significant statistical difference in terms of COX-2 expression was found between pancreaticobiliary vs intestinal type (P=0.002). Furthermore, a negative significant statistical correlation was found between T factor and COX-2 expression (P=0.047). The different COX-2 expression among histopathological types supports the concept of histogenetical difference of ampullary carcinomas. Furthermore, the high rate of COX-2 expression in the intestinal subtype of ampullary carcinoma may represent the rational for a histotype-tailored therapy targeting COX-2.
KeywordsVater Ampulla Cancer Histotype COX-2
We thank Alessandra Innocenzi and Giorgio Lescarini for technical support and Maria Crapulli for useful collaboration. The experiments comply with the current laws of the country in which they were performed.
- 2.Albores-Saavedra J, Henson DE, Klimstra DS (2000) Tumors of the gallbladder, extrahepatic bile duct, and ampulla of Vater. In: Rosai J, Sobin L (eds) Atlas of tumor pathology, 3rd series, fascicle 27. Armed Forces Institute of Pathology, Washington DC, pp 259–316Google Scholar
- 23.Perrone G, Santini D, Verzi A, Vincenzi B, Borzomati D, Vecchio F, Coppola R, Antinori A, Magistrelli P, Tonini G, Rabitti C (2006) COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological parameters. J Clin Pathol 59(5):492–496PubMedCrossRefGoogle Scholar
- 24.Perrone G, Santini D, Vincenzi B, Zagami M, La Cesa A, Bianchi A, Altomare V, Primavera A, Battista C, Vetrani A, Tonini G, Rabitti C (2005) COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features. Histopathology 46:561–568PubMedCrossRefGoogle Scholar
- 26.Rosai J (2004) Appendix E. In: Rosai and Ackerman’s surgical pathology, 9th edn. Mosby, Edinburgh, pp 2953–2954Google Scholar
- 28.Santini D, Vincenzi B, Tonini G, Scarpa S, Vasaturo F, Malacrino C, Vecchio F, Borzomati D, Valeri S, Coppola R, Magistrelli P, Nuzzo G, Picciocchi A (2005) Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients. Clin Cancer Res 11:3784–3789PubMedCrossRefGoogle Scholar
- 31.Sobin LH, Wittekind C (2002) TNM Classification of malignant tumours, 6th edn. UICC International Union Against Cancer, Wiley-Liss, New YorkGoogle Scholar